CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-arm, Phase II Study of Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05030077
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:31.305978+00:00
Published At: 2021-09-01T00:00:00+00:00
Record Updated At: 2021-09-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urothelial Carcinoma", "Anlotinib", "Urogenital Neoplasms", "Cisplatin", "Carboplatin", "Gemcitabine", "Antineoplastic Agents"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-09-01"
protocolSection.identificationModule.nctId: "NCT05030077"
protocolSection.identificationModule.officialTitle: "A Single-arm, Phase II Study of Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.